CAR-T cells targeting GPC3 and EGFR (CARgpc3-egfr) have been developed and demonstrated comparable proliferative capacity and cytotoxicity to CARgpc3 T cells against GPC3 + EGFR+ hepatocellular carcinoma (HCC) in vitro. This evidence concerns the gene EGFR and hepatocellular carcinoma.